Found: 99
Select item for more details and to access through your institution.
Kernel-based logistic regression model for protein sequence without vectorialization.
- Published in:
- Biostatistics, 2015, v. 16, n. 3, p. 480, doi. 10.1093/biostatistics/kxu056
- By:
- Publication type:
- Article
Magnitude, Specificity, and Avidity of Sporozoite-Specific Antibodies Associate With Protection Status and Distinguish Among RTS,S/AS01 Dose Regimens.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofaa644
- By:
- Publication type:
- Article
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv082
- By:
- Publication type:
- Article
Methods for comparing durability of immune responses between vaccine regimens in early-phase trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1011569
- By:
- Publication type:
- Article
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
FCCR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 9, p. 3879, doi. 10.1172/JCI75539
- By:
- Publication type:
- Article
CD4 T follicular helper cell dynamics during SIV infection.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 9, p. 3281, doi. 10.1172/JCI63039
- By:
- Publication type:
- Article
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4 + T-Cells.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1662, doi. 10.3390/vaccines11111662
- By:
- Publication type:
- Article
Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.983313
- By:
- Publication type:
- Article
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.939627
- By:
- Publication type:
- Article
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.788619
- By:
- Publication type:
- Article
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.787603
- By:
- Publication type:
- Article
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670561
- By:
- Publication type:
- Article
COMPASS identifies T-cell subsets correlated with clinical outcomes.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 610, doi. 10.1038/nbt.3187
- By:
- Publication type:
- Article
Lessons from babies: inducing HIV-1 broadly neutralizing antibodies.
- Published in:
- Nature Medicine, 2014, v. 20, n. 6, p. 583, doi. 10.1038/nm.3598
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV-1 Recombinant Canarypox Vaccine in Newborns and Infants of HW-1--Infected Women.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 12, p. 2129, doi. 10.1086/498163
- By:
- Publication type:
- Article
High-Dose Recombinant Canarypox Vaccine Expressing HIV-1 Protein, in Seronegative Human Subjects.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 7, p. 1249
- By:
- Publication type:
- Article
Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01407
- By:
- Publication type:
- Article
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101863
- By:
- Publication type:
- Article
DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091550
- By:
- Publication type:
- Article
<i>IGHV</i>1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090725
- By:
- Publication type:
- Article
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075665
- By:
- Publication type:
- Article
Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037648
- By:
- Publication type:
- Article
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024517
- By:
- Publication type:
- Article
A Phase IIA Randomized Clinical Trial of a Multiclade HIV- 1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204).
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0021225
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054).
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013579
- By:
- Publication type:
- Article
Tat-SF1 Is Not Required for Tat Transactivation but Does Regulate the Relative Levels of Unspliced and Spliced HIV-1 RNAs.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005710
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 6, p. 947, doi. 10.1093/infdis/jiu522
- By:
- Publication type:
- Article
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 10, p. 1541, doi. 10.1093/infdis/jir615
- By:
- Publication type:
- Article
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 8, p. 1165
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 610
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 610
- By:
- Publication type:
- Article
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 6, p. 1, doi. 10.1371/journal.ppat.1009624
- By:
- Publication type:
- Article
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
- Published in:
- PLoS Pathogens, 2021, p. 1, doi. 10.1371/journal.ppat.1009363
- By:
- Publication type:
- Article
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.69577
- By:
- Publication type:
- Article
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02875
- By:
- Publication type:
- Article
IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02582
- By:
- Publication type:
- Article
Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaques.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11814-5
- By:
- Publication type:
- Article
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10899-2
- By:
- Publication type:
- Article
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08854-2
- By:
- Publication type:
- Article
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08739-4
- By:
- Publication type:
- Article
Development of flow cytometry‐based assays to assess the ability of antibodies to bind to SARS‐CoV‐2‐infected and spike‐transfected cells and mediate NK cell degranulation.
- Published in:
- Cytometry. Part A, 2022, v. 101, n. 6, p. 483, doi. 10.1002/cyto.a.24552
- By:
- Publication type:
- Article
Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay.
- Published in:
- Cytometry. Part A, 2018, v. 93, n. 4, p. 436, doi. 10.1002/cyto.a.23348
- By:
- Publication type:
- Article
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
- Published in:
- Cytometry. Part A, 2011, v. 79A, n. 8, p. 603, doi. 10.1002/cyto.a.21084
- By:
- Publication type:
- Article
Quality control, analysis and secure sharing of Luminex immunoassay data using the open source LabKey Server platform.
- Published in:
- BMC Bioinformatics, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2105-14-145
- By:
- Publication type:
- Article
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.ppat.1006986
- By:
- Publication type:
- Article
The immune response during acute HIV-1 infection: clues for vaccine development.
- Published in:
- 2010
- By:
- Publication type:
- journal article